The realization that Vκ*MYC-dependent myeloma causes changes in immune regulation in mice comparable to changes seen in patients with myeloma (145) laid the foundation for mechanistic studies describing role of specific pathways of immunity to Vκ*MYC-driven tumor development. Here, MYC is linked to plasma cell myeloma.